DIGIPATH INC - DIGP STOCK NEWS

Hypha Labs (OTC PINK:DIGP) has expanded its patent portfolio with new filings at the USPTO for novel methods and devices in mycelium processing. The company aims to develop the first in-home device for producing functional mushroom ingredients in less than ten days, with greater potency precision and at lower costs than current market options.

Key points:

• The U.S. functional and psychedelic mushroom market reached $3.6 billion in 2022, with expected 12.1% CAGR from 2023 to 2030.
• Hypha Labs is using AI and machine learning to optimize mycelium processing for extracting active components like psilocybin.
• The new methods aim to overcome traditional challenges in mycelium processing, offering faster cultivation times and more efficient production.

Hypha Labs (OTC PINK:DIGP), a pioneer in functional mushroom sciences, has retained Integrity Media for Investor Relations and Corporate Communication. Integrity Media, led by Founder & President Kurt Divich, brings over 25 years of experience in public markets.

Stone Douglass, CEO of Hypha Labs, praised Integrity Media's reputation and extensive media relationships, particularly in their desired vertical. Kurt Divich expressed excitement about representing Hypha Labs, viewing their technology as potentially market-disruptive in a rapidly growing industry.

Divich drew parallels between the functional mushroom category and the emergent cannabis industry a decade ago, highlighting Hypha's novel device and its potential for widespread commercial appeal. He believes this could indicate significant market potential for the company.

Hypha Laboratories (OTC PINK:DIGP) has announced the addition of new patent applications to its portfolio, aimed at revolutionizing mycelium extraction through AI-driven methods. The patents cover novel methods and devices designed to efficiently extract active components like psilocybin from mycelium. The company plans to introduce the first in-home device for producing mushroom-based ingredients, promising faster growth cycles and higher potency at lower costs. The U.S. market for functional and psychedelic mushrooms was valued at USD 3.6 billion in 2022, with a projected CAGR of 12.1% from 2023 to 2030. Hypha's AI integration aims to optimize growth conditions, accelerate processing times, and enhance yield predictability, presenting significant benefits for pharmaceuticals, nutraceuticals, and biotechnology sectors.

Hypha Labs has engaged Integrity Media to handle its Investor Relations and Corporate Communications. Integrity Media, led by founder Kurt Divich, brings over 25 years of experience in public markets in the U.S. and Canada. Divich has a reputation for excellence in corporate communication and has worked with both leading companies and emerging market disruptors. Hypha Labs aims to leverage Integrity Media's extensive media relationships as it grows in the functional mushroom science industry. CEO Stone Douglass emphasized Integrity Media's dual role in conveying company information and advocating for shareholders. Divich expressed enthusiasm for representing Hypha Labs, likening its market potential to the early cannabis industry.

Hypha Labs announces a new patent portfolio aimed at revolutionizing psilocybin processing. The initial filing with the United States Patent and Trademark Office (USPTO) in March 2024 includes innovative methods and devices to enhance the extraction of mycelium's active components. This development is particularly significant given the $3.6 billion U.S. market for functional and psychedelic mushrooms, expected to grow at a CAGR of 12.1% from 2023 to 2030. The new techniques developed by Hypha Labs aim to bypass traditional, lengthy cultivation methods, offering a more efficient and sustainable approach. The patents cover a range of devices suitable for both industrial and consumer use, making mycelium processing more accessible. CEO A. Stone Douglass emphasizes the importance of these innovations in driving sustainable solutions for a healthier future. The company remains committed to collaboration and further research in mycological sciences.

Hypha Labs, Inc. has appointed Craig Ellins as its Chief Science Officer, known for his expertise in emerging technologies and industries. The company focuses on developing cutting-edge technology for producing active ingredients in functional mushrooms like psilocybin using bioreactors. Aiming to revolutionize the field, they offer pure, consistent, and measurable doses in an easily digestible form for consumer and commercial use. Their technology reduces production time significantly compared to traditional methods, offering a subscription-based service for home use. With the rise of clinical trials showcasing the benefits of functional mushrooms, Hypha Labs is positioned as a key player in this emerging market.

Hypha Labs, Inc. (OTC PINK:DIGP) changes its name from Digipath, Inc. to focus on producing active ingredients from functional mushrooms like psilocybin using innovative bioreactor technology. The company aims to offer pure, consistent, and measurable doses of these ingredients for consumer and commercial use. With a subscription-based model, Hypha Labs plans to revolutionize the production of functional mushrooms, tapping into the growing market for psychedelic and functional mushrooms as potential treatments for various health conditions.

Hypha Labs, Inc. will present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024. Stone Douglass and Craig Ellins will host the presentation. Investors can book 1x1 meetings at the Paris Hotel & Casino in Las Vegas.

Lab Operations sees increased revenue and gross margins, with earnings of $292,533 in Q3 2023 compared to ($576,733) in the same quarter last year. Revenues were $787,549 in the last quarter versus $680,275 in the previous year. Net income was $231,795 compared to ($44,777) last year. Increased sample flow from old and new customers is a positive sign for the industry. Digipath, Inc. plans to sell assets of Digipath Labs, Inc. pending approval from the Nevada Cannabis Control Board.